Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/14/2025

Omeprazole and Antibiotic Use for Urinary Tract Infections

Drug Interaction Considerations

  • The American Urological Association recommends that omeprazole can be safely taken with antibiotics prescribed for a urinary tract infection, including trimethoprim-sulfamethoxazole, nitrofurantoin, fosfomycin, or fluoroquinolones, without clinically significant interactions or contraindications 1, 2.
  • The primary antibiotics recommended for UTI treatment, such as trimethoprim-sulfamethoxazole, nitrofurantoin, and fosfomycin, can be administered concurrently with omeprazole without dose adjustments 1, 2.

Potential Gastrointestinal Benefits

  • Antibiotics commonly used for UTI treatment, including trimethoprim, trimethoprim-sulfamethoxazole, cephalexin, and fosfomycin, can cause gastrointestinal disturbances as adverse effects, and omeprazole may provide symptomatic relief for patients with underlying gastroesophageal reflux disease or antibiotic-associated dyspepsia 1, 2.

Important Clinical Context

  • The Infectious Diseases Society of America guidelines focus on antibiotic selection, duration, and resistance patterns for UTI treatment, with no mention of omeprazole or other proton pump inhibitors as contraindications or concerns 1, 2, 3.
  • For men with UTI, treatment duration is 14 days when prostatitis cannot be excluded, with trimethoprim-sulfamethoxazole or fluoroquinolones (if local resistance <10%) as preferred agents 3, 4.

Common Pitfalls to Avoid

  • The American College of Gastroenterology recommends that necessary acid suppression therapy, such as omeprazole, should not be discontinued unnecessarily when starting antibiotics for UTI, as there is no medical indication to do so 1, 2.
  • Antibiotic selection should be based on local resistance patterns and patient-specific factors, rather than concerns about omeprazole co-administration, according to the Centers for Disease Control and Prevention 1, 2.
  • The FDA warns against using fluoroquinolones as first-line agents for uncomplicated UTI due to serious adverse effects and the need for antimicrobial stewardship 4.

REFERENCES

3

Treatment of Male Urinary Tract Infections [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4

Antibiotic Treatment for Urinary Tract Infections in Men [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026